A H Prowse

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. pmc Identification of a splice acceptor site mutation in p16INK4A/p14ARF within a breast cancer, melanoma, neurofibroma prone kindred
    A H Prowse
    Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    J Med Genet 40:e102. 2003
  2. ncbi request reprint Disabled-2 mediates c-Fos suppression and the cell growth regulatory activity of retinoic acid in embryonic carcinoma cells
    E R Smith
    Ovarian Cancer Program, Fox Chase Cancer Center, 7701 Burholme Ave, Philadelphia, PA 19111, USA
    J Biol Chem 276:47303-10. 2001
  3. ncbi request reprint Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells
    W Bruening
    Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Cancer Res 59:4973-83. 1999

Collaborators

  • E R Smith
  • A K Godwin
  • W Bruening
  • X X Xu
  • C D Capo-chichi
  • D H Yang
  • J He
  • T C Hamilton
  • J L Smedberg
  • D C Schultz
  • A Wong
  • M Holgado-Madruga

Detail Information

Publications3

  1. pmc Identification of a splice acceptor site mutation in p16INK4A/p14ARF within a breast cancer, melanoma, neurofibroma prone kindred
    A H Prowse
    Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    J Med Genet 40:e102. 2003
  2. ncbi request reprint Disabled-2 mediates c-Fos suppression and the cell growth regulatory activity of retinoic acid in embryonic carcinoma cells
    E R Smith
    Ovarian Cancer Program, Fox Chase Cancer Center, 7701 Burholme Ave, Philadelphia, PA 19111, USA
    J Biol Chem 276:47303-10. 2001
    ..Resistance to retinoic acid regulation in PA-1 cells likely results from defects in retinoic acid up-regulation of Dab2 expression...
  3. ncbi request reprint Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells
    W Bruening
    Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Cancer Res 59:4973-83. 1999
    ..These results suggest that slight alterations in the level of OVCA1, such as would occur after reduction of chromosome 17p13.13 to hemizygosity, may result in cell cycle deregulation and promote tumorigenesis...